ScoreWhy is Lincoln Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 9.03% and Operating profit at 3.19% over the last 5 years
3
Flat results in Dec 25
- ROCE(HY) Lowest at 15.46%
- PBDIT(Q) Lowest at Rs 23.59 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at 14.18%
4
With ROE of 11.2, it has a Fair valuation with a 1.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 6.68%, its profits have fallen by -1.7%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Market Beating performance in long term as well as near term
- Along with generating 6.68% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Lincoln Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Lincoln Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Lincoln Pharma.
7.01%
0.18
36.72%
Sensex
-3.52%
-0.27
12.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.03%
EBIT Growth (5y)
3.19%
EBIT to Interest (avg)
54.62
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
1.00
Tax Ratio
23.73%
Dividend Payout Ratio
4.38%
Pledged Shares
0
Institutional Holding
4.71%
ROCE (avg)
22.49%
ROE (avg)
14.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
32
Price to Book Value
1.65
EV to EBIT
11.14
EV to EBITDA
9.57
EV to Capital Employed
1.97
EV to Sales
1.46
PEG Ratio
NA
Dividend Yield
0.30%
ROCE (Latest)
17.79%
ROE (Latest)
11.18%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
PAT(Q)
Highest at Rs 28.60 cr.
EPS(Q)
Highest at Rs 14.28
-6What is not working for the Company
ROCE(HY)
Lowest at 15.46%
PBDIT(Q)
Lowest at Rs 23.59 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 14.18%
PBT LESS OI(Q)
Lowest at Rs 19.57 cr.
NON-OPERATING INCOME(Q)
is 43.63 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Lincoln Pharma.
Profit After Tax (PAT) - Quarterly
Highest at Rs 28.60 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 28.60 cr has Grown at 37.7%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 14.28
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Lincoln Pharma.
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 23.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 14.18%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 19.57 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 43.63 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
